- Home
- DAWN vs BELFB Comparison
DAWN vs BELFB Comparison
Compare DAWN & BELFB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DAWN | BELFB |
|---|---|---|
| Founded | 2018 | 1949 |
| Country | United States | United States |
| Employees | N/A | 4964 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.6B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | DAWN | BELFB |
|---|---|---|
| Price | $21.42 | $203.87 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 4 |
| Target Price | $26.00 | ★ $174.25 |
| AVG Volume (30 Days) | ★ 6.4M | 131.7K |
| Earning Date | 05-05-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 0.14% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $158,182,000.00 | N/A |
| Revenue This Year | $55.03 | $28.52 |
| Revenue Next Year | $28.12 | $7.85 |
| P/E Ratio | ★ N/A | $42.80 |
| Revenue Growth | ★ 20.60 | N/A |
| 52 Week Low | $5.64 | $58.00 |
| 52 Week High | $21.46 | $248.61 |
Technical Indicators
Market Signals| Indicator | DAWN | BELFB |
|---|---|---|
| Relative Strength Index (RSI) | 81.44 | 45.03 |
| Support Level | $10.30 | $130.49 |
| Resistance Level | N/A | $248.61 |
| Average True Range (ATR) | 0.07 | 10.04 |
| MACD | -0.16 | 0.25 |
| Stochastic Oscillator | 79.55 | 27.45 |
Price Performance
Historical ComparisonAbout DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY301 is an antibody drug conjugate (ADC) that has shown antitumor activity in preclinical models.
About BELFB Bel Fuse Inc. Class B
Bel Fuse Inc designs and manufactures electronic components that protect and connect electronic circuits. Its product portfolio is divided into three categories: magnetic solutions, power solutions & protection, and connectivity solutions. These products are used for the computer, networking, telecommunications, transportation and defense/aerospace, automotive, medical, and consumer electronics industries. Its geographical segments are the United States, Macao, United Kingdom, Slovakia, Germany, Switzerland, and All other foreign countries. Majority of the revenue is derived from United States.